Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8188 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8101 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8101 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7974 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7911 |
Intermediate Similarity |
NPD37 |
Approved |
0.7862 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7815 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD1357 |
Approved |
0.777 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7671 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7609 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.76 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7576 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7536 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7533 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7157 |
Approved |
0.75 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7432 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7368 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7355 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7341 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7299 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7288 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD228 |
Approved |
0.719 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7118 |
Intermediate Similarity |
NPD3051 |
Approved |
0.711 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7108 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7076 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7071 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7071 |
Intermediate Similarity |
NPD3021 |
Approved |
0.707 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7047 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD5772 |
Approved |
0.698 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.697 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD2677 |
Approved |
0.6948 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD7906 |
Approved |
0.6943 |
Remote Similarity |
NPD7119 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD3060 |
Approved |
0.6937 |
Remote Similarity |
NPD4162 |
Approved |
0.6936 |
Remote Similarity |
NPD2489 |
Approved |
0.6936 |
Remote Similarity |
NPD27 |
Approved |
0.6933 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6933 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6928 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3657 |
Discovery |
0.6923 |
Remote Similarity |
NPD5535 |
Approved |
0.6909 |
Remote Similarity |
NPD3687 |
Approved |
0.6909 |
Remote Similarity |
NPD3686 |
Approved |
0.6909 |
Remote Similarity |
NPD4210 |
Discontinued |
0.6905 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD5494 |
Approved |
0.6899 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6897 |
Remote Similarity |
NPD6671 |
Approved |
0.6894 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6894 |
Remote Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD52 |
Approved |
0.689 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD7526 |
Approved |
0.689 |
Remote Similarity |
NPD6273 |
Approved |
0.6872 |
Remote Similarity |
NPD8054 |
Approved |
0.6872 |
Remote Similarity |
NPD8053 |
Approved |
0.6871 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD2231 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD1608 |
Approved |
0.6867 |
Remote Similarity |
NPD2235 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6864 |
Remote Similarity |
NPD2560 |
Approved |
0.6864 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD2563 |
Approved |
0.6864 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6854 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6852 |
Remote Similarity |
NPD6190 |
Approved |
0.6852 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6842 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD7007 |
Discovery |
0.6832 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6829 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD3882 |
Suspended |
0.6824 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6821 |
Remote Similarity |
NPD4749 |
Approved |
0.6821 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD7312 |
Approved |
0.6816 |
Remote Similarity |
NPD7311 |
Approved |
0.6816 |
Remote Similarity |
NPD7313 |
Approved |
0.6816 |
Remote Similarity |
NPD7310 |
Approved |
0.6815 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6813 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6813 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6813 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6813 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD290 |
Approved |
0.6805 |
Remote Similarity |
NPD2801 |
Approved |
0.6803 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.68 |
Remote Similarity |
NPD7473 |
Discontinued |
0.68
|
Remote Similarity |
NPD3092 |
Approved |